Abstract |
Six new 4-hydroxycoumarin derivatives have been synthesized. They were characterized by UV-vis, IR, (1)H NMR, (13)C NMR, mass spectral data, elemental analysis, TLC and melting point determination. The new 4-hydroxycoumarin derivatives are studied by computational methods--DFT (B3LYP) and force field methods (MM2 and OPLS), in order to optimize their geometry and calculate quantum-chemical properties and conformational analysis. Five new 4-hydroxycoumarin derivatives were tested for cytotoxic activity in two tumor cell lines--HL-60 and EJ. The obtained results are compared with the utilized anticancer drug melphalan. Two of these compounds--ethyl 2-[(3,4-dihydroxyphenyl)(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-3-oxobutanoate (SS-16) and ethyl 2-[(4-hydroxy-2-oxo-2H-chromen-3-yl)(3-nitrophenyl)methyl]-3-oxobutanoate (SS-21) show comparatively good cytotoxic properties. Their activity is weaker than melphalan. SS-16 seems to be more active than SS-21.
|
Authors | Stancho Stanchev, Georgi Momekov, Frank Jensen, Ilia Manolov |
Journal | European journal of medicinal chemistry
(Eur J Med Chem)
Vol. 43
Issue 4
Pg. 694-706
(Apr 2008)
ISSN: 0223-5234 [Print] France |
PMID | 17614164
(Publication Type: Journal Article)
|
Chemical References |
- 4-Hydroxycoumarins
- Antineoplastic Agents
- Melphalan
- 4-hydroxycoumarin
|
Topics |
- 4-Hydroxycoumarins
(chemical synthesis, chemistry, pharmacology)
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Computational Biology
- Drug Screening Assays, Antitumor
- HL-60 Cells
(drug effects)
- Humans
- Melphalan
(pharmacology)
- Models, Molecular
- Molecular Structure
- Spectrophotometry, Infrared
|